2019 American Transplant Congress » Concurrent Session: Kidney: Pediatrics II
Date: Monday, June 3, 2019
Time: 4:30pm-6:00pm
Location: Room 304
Session Type: Concurrent Session
Meeting: 2019 American Transplant Congress
- 4:30pm-4:42pm
Increase in 48 Month Cumulative Acute Rejection Rates in the Most Recent Cohort: The 2018 Transplant Report of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS)
V. Dharnidharka1, C. Cramer2, A. Chua3, A. Moudgil4, K. Martz5, T. Blydt-Hansen6, J. Smith7, A. Neu, on Behalf of The NAPRTCS Investigators8
- 4:42pm-4:54pm
Epstein Barr Virus (EBV)-Specific T Cells as a Diagnostic Marker for the Individual EBV-Specific Immune Response after Pediatric Kidney Transplantation
T. Ahlenstiel-Grunow, L. Pape
- 4:54pm-5:06pm
Standardizing Blood Pressure Measurement across 17 Pediatric Transplant Centers: The Improving Renal Outcomes Collaborative
M. E. Seifert1, R. Garro2, R. P. George2, G. Barletta3, C. W. Belsha4, A. Chaudhuri5, J. W. Goebel6, L. Wickman7, D. Matossian8, J. Misurac9, C. Nailescu10, C. R. Nguyen11, M. Pearl12, A. Pollack13, C. S. Pruette14, P. Singer15, P. S. Verghese16, B. A. Warady17, D. S. Dahale18, D. K. Hooper18
- 5:06pm-5:18pm
Elevated Donor Derived Cell Free DNA (dd-cfDNA) Levels in the Presence of Donor Specific Antibodies (DSA) Are a Strong Predictor of Antibody Mediated Rejection (ABMR) in Pediatric Renal Transplant Recipients
D. Puliyanda1, R. D. Swinford2, H. Pizzo1, J. Garrison1, I. Kim1, A. M. De Golovine2, S. Jordan1
- 5:18pm-5:30pm
Tocilizumab for Refractory Antibody-Mediated Rejection in Pediatric Kidney Transplantation
A. Dokras, C. Butler, Q. Zhang, E. Reed, R. Ettenger, P. Weng, M. Pearl
- 5:30pm-5:42pm
Antithymocyte Globulin is Associated with Mature T Cell Phenotypes and Decreased Risk of Non-EBV Infections in Transplanted Children
B. I. Shaw1, L. Stempora1, C. Chan1, R. B. Ettenger2, P. C. Grimm3, H. Lee1, E. F. Reed2, M. M. Sarwal4, B. L. Warshaw5, C. Zhao1, O. M. Martinez3, A. D. Kirk1, E. T. Chambers1
- 5:42pm-5:54pm
Successful Use of Hizentra to Address BK Viremia in Pediatric Transplant Population
K. Gruenkemeyer, E. Wood, A. Beck, C. Belsha
« View all sessions from the 2019 American Transplant Congress